No Detail Found!

Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia

Author(s)
Saira Bashir PMRC, Research Centre, Fatima Jinnah Medical College,Lahore,Pakistan
Misbah Ul Islam Khan Sherwani PMRC, Research Centre, Fatima Jinnah Medical College,Lahore,Pakistan
Iffat Shabbir PMRC, Research Centre, Fatima Jinnah Medical College,Lahore,Pakistan
Asia Batool PMRC, Research Centre, Fatima Jinnah Medical College,Lahore,Pakistan
Abstract
Background: The fixed-dose combination containing the antihypertensive agent amlodipine and the statin, atorvastatin, is the first combination of its kind designed to treat two risk factors for cardiovascular disease (CVD), i.e., hypertension and dyslipidemia. In this study, blood pressure and lipid lowering effects of combination of amlodipine and atorvastatin were evaluated in uncontrolled hypertensive patients. Methods: Thirty patients both male and female in the age group 35-60 years attending the Hypertensive Clinic of PMRC FJMC suffering from uncontrolled hypertension were selected. Baseline blood pressure was checked after half hour rest in sitting and standing position using mercury sphygmomanometer. Blood sample was collected from all patients after overnight fasting for assessment of serum cholesterol, triglycerides, LDL and HDL cholesterol levels. They were prescribed with fixed dose combination of 5 mg amlodipine and 10 mg atorvastatin. Patients were followed for their blood pressure measurement after every 4 weeks up to 12 weeks. At the end of 12 weeks their fasting blood sample was taken again for determination of serum cholesterol, triglyceride, LDL and HDL cholesterol levels. Results: Systolic blood pressure after 4, 8 and 12 weeks was significantly lower at all intervals from baseline. When systolic blood pressure after 8 and 12 weeks was compared with 4 weeks, the effect was again significant (p=0.024, p=0.002 respectively).There was no significant reduction seen in 8 versus 12 weeks (p=0.493). Diastolic blood pressure at 4, 8 and 12 weeks was significantly lower from baseline. Diastolic blood pressure after 4 and 8 weeks when compared with 8 and 12 weeks was not significantly low (p=0.99 and 0.91 respectively). Lipid profile of the patients was significantly reduced from baseline after twelve weeks of fixed dose combination of treatment (p<0.000). Conclusion: Combination therapy proved to be effective in controlling hypertension and dyslipidemia than single pill. It also improved patient's compliance. It is suggested that polypill should be prescribed instead of multiple drugs.
Publication Details
Page(s) 97-100
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 23, Issue: 3, Year: 2011

Request the full text from PASTIC

Keywords
Dyslipidemia, atorvastatin, Amlodipine, Combination therapy, uncontrolled hypertension
0

Citations

0

Downloads

95

Views